Arthur Fratamico Insider Trading Transactions
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for Arthur Fratamico.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of Arthur Fratamico. Arthur Fratamico is Chief Business Officer in Vitae Pharmaceuticals, Inc ($VTAE) and Director in Sun BioPharma, Inc. ($SNBP).
Latest Insider Trading Transactions of Arthur Fratamico
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 03 2020 | SNBP | Panbela Therapeuti ... | Fratamico Arthur | Director | Grant | A | 0.00 | 2,875 | 0 | 5,299 | 2.4 K to 5.3 K (+118.61 %) |
| Sep 01 2020 | SNBP | Sun BioPharma, Inc ... | Fratamico Arthur | Director | Option Exercise | P | 4.54 | 2,424 | 11,005 | 2,424 | |
| Sep 01 2020 | SNBP | Sun BioPharma, Inc ... | Fratamico Arthur | Director | Buy | P | 0.00 | 2,424 | 0 | 2,424 | 0 to 2.4 K |
| Jun 26 2020 | SNBP | Sun BioPharma, Inc ... | Fratamico Arthur | Director | Option Exercise | A | 4.98 | 12,000 | 59,760 | 12,000 | |
| Dec 23 2019 | SNBP | Sun BioPharma, Inc ... | Fratamico Arthur | Director | Option Exercise | A | 3.70 | 26,800 | 99,160 | 26,800 | |
| Dec 23 2019 | SNBP | Sun BioPharma, Inc ... | Fratamico Arthur | Director | Option Exercise | A | 3.70 | 6,500 | 24,050 | 6,500 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Fratamico Arthur | Chief Business Offi ... | Option Exercise | D | 8.78 | 14,500 | 127,310 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Fratamico Arthur | Chief Business Offi ... | Option Exercise | D | 8.58 | 19,250 | 165,165 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Fratamico Arthur | Chief Business Offi ... | Option Exercise | D | 8.28 | 13,750 | 113,850 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Fratamico Arthur | Chief Business Offi ... | Option Exercise | D | 14.40 | 13,750 | 198,000 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Fratamico Arthur | Chief Business Offi ... | Option Exercise | D | 5.29 | 152,173 | 804,995 | 0 | |
| Oct 25 2016 | VTAE | Vitae Pharmaceutic ... | Fratamico Arthur | Chief Business Offi ... | Sell | U | 21.00 | 13,233 | 277,893 | 0 | 13.2 K to 0 (-100.00 %) |
| Aug 17 2016 | VTAE | Vitae Pharmaceutic ... | Fratamico Arthur | Chief Business Offi ... | Option Exercise | A | 8.79 | 14,500 | 127,455 | 14,500 | |
| Aug 17 2016 | VTAE | Vitae Pharmaceutic ... | Fratamico Arthur | Chief Business Offi ... | Grant | A | 6.11 | 2,086 | 12,745 | 12,086 | 10 K to 12.1 K (+20.86 %) |
| Feb 16 2016 | VTAE | Vitae Pharmaceutic ... | Fratamico Arthur | Chief Business Offi ... | Option Exercise | A | 8.58 | 19,250 | 165,165 | 19,250 | |
| Aug 31 2015 | VTAE | Vitae Pharmaceutic ... | Fratamico Arthur | Chief Business Offi ... | Buy | P | 7.83 | 10,000 | 78,266 | 10,000 | 0 to 10 K |
Page: 1